|
Orenes-Piñero E, Ruiz-Nodar JM, Esteve-Pastor MA, Quintana-Giner M, Rivera-Caravaca JM, Veliz A, Valdés M, Macías M, Pernias-Escrig V, Vicente-Ibarra N, Carrillo L, Sandín-Rollán M, Candela E, Lozano T, Marín F. Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome. Oncotarget. 2017 Sep 24;8(46):80182-80191. doi: 10.18632/oncotarget.21260. eCollection 2017 Oct 6. PubMed PMID: 29113294; PubMed Central PMCID: PMC5655189.
AÑO: 2017; IF: 5.168
|
29113294
|
Tello-Montoliu A, Rivera J, Hernández D, Silvente A, Jover E, Rodriguez AI, Quintana M, Romero A, Orenes-Piñero E, Rivera-Caravaca JM, Marín F, Veliz A, Valdés M. Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation. Circ J. 2018 Jan 25;82(2):353-360. doi: 10.1253/circj.CJ-17-0471. Epub 2017 Sep 6. PubMed PMID: 28883222.
AÑO: 2018; IF: 3.025
|
|
Esteve-Pastor MA, Ruíz-Nodar JM, Orenes-Piñero E, Rivera-Caravaca JM, Quintana-Giner M, Véliz-Martínez A, Tello-Montoliu A, PerniasEscrig V, Sandín Rollán M, Vicente-Ibarra N, MacíasVillanego MJ, Candela Sánchez E, Carrillo Alemán L, Lozano T, Valdés M, Marín F. Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes. J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):57-65. doi: 10.1177/1074248417724869. Epub 2017 Aug 9. PubMed PMID: 28789568.
AÑO: 2018; IF: 2.57
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Lip GYH. Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks. Am J Hypertens. 2017 Nov 1;30(11):1063-1065. doi: 10.1093/ajh/hpx135. PubMed PMID: 28985289.
AÑO: 2017; IF: 3.046
|
|
Rivera-Caravaca JM, Lip GYH. Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation. Evid Based Med. 2017 Aug;22(4):154-155. doi: 10.1136/ebmed-2017-110764. Epub 2017 Jul 13. PubMed PMID: 28705921.
AÑO: 2017
|